Cristina Rodríguez‐Gutiérrez

EFECTIVIDAD DEL USO DE UN FÁRMACO ANTI-TNF TRAS OTRO CON UN MECANISMO DE ACCIÓN DIFERENTE: EVIDENCIA DE PRÁCTICA CLÍNICA DEL REGISTRO ENEIDA

Diego Casas Deza, Carmen Yagüe Caballero, Ana Royo Esteban, Laura Figueras Padillo et autres

31 - IMPORTANCIA DE LA SECUENCIA DE LOS DOS PRIMEROS TRATAMIENTOS BIOLÓGICOS EN LA ENFERMEDAD INFLAMATORIA INTESTINAL. ESTUDIO SECUTEM DEL REGISTRO ENEIDA

Diego Casas Deza, Carmen Yagüe Caballero, Ana Royo Esteban, Laura Figueras Panillo et autres

Anti-EPCR autoantibodies in ulcerative colitis show sex- and lipid-dependent patterns

Nerea Ugidos-Damboriena, Llucia Jaime-Gomez, Cristina Rodríguez‐Gutiérrez, Lucía Zabalza et autres

es (code pays fourni par la source)

Frequency and Effectiveness of Dose Escalation and De‐Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW ‐ IBD Study of ENEIDA

Cristina Rubín de Célix, Elena Ricart, María Dolores Martín‐Arranz, Ruth de Francisco et autres

es, mx, us (code pays fourni par la source)

P0226 Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry

M Calafat Sard, Míriam Mañosa, A Fernández-Clotet, Laura Pasanau et autres

es (code pays fourni par la source)

RECURRENCIA POSQUIRÚRGICA EN PACIENTES CON OSTOMÍA DEFINITIVA EN LA ENFERMEDAD DE CROHN. SERIE RETROSPECTIVA A NIVEL NACIONAL DEL REGISTRO ENEIDA

Margalida Calafat, Míriam Mañosa, Agnès Fernández-Clotet, Laura Pasanau et autres

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

Yamile Zabana, Ignacio Marín‐Jiménez, Iago Rodríguez–Lago, Isabel Vera et autres

es (code pays fourni par la source)

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

Yamile Zabana, Ignacio Marín‐Jiménez, Iago Rodríguez–Lago, Isabel Vera et autres

es (code pays fourni par la source)

P391 The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn’s disease but not in ulcerative colitis. A nationwide study from the Eneida registry

Montserrat Guasch, Ariadna Clos, Íngrid Ordás, Valle García-Sánchez et autres

es (code pays fourni par la source)

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

Marisa Iborra, Javier P. Gisbert, Marta Maia Boscá-Watts, Alicia López‐García et autres

es (code pays fourni par la source)

Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

Marisa Iborra, Javier P. Gisbert, Marta Maia Boscá-Watts, Alicia López‐García et autres

es (code pays fourni par la source)